Sequence Variation Analysis of HPV-18 Isolates in Southwest China

Shen, Mengjie; Ding, Xianping; Li, Tianjun; Chen, Gangyi; Zhou, Xiao
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Intratypic variations of HPV-18 are known to differ in the persistence of the infection, frequency of carcinogenesis and the progression of precursor lesions to advanced cervical cancer. This study was designed to analyze sequence variations of HPV-18 isolates in order to discover novel HPV-18 variants and to evaluate the variations among infected women in southwest China. Cervical biopsies from 56 HPV-18-positive women with cervical neoplasia were assayed by PCR amplification and sequencing of all eight genes (E1, E2, E4, E5, E6, E7, L1, L2) of the HPV-18 genome. The most frequently observed variation was a C to G transversion at nucleotide 287 of E6, which was found in 48.2% of samples. Analysis of E7 revealed only one specimen as having sequence variations. In addition, we have identified several novel variations: A551C in E6, G6906A in L1, and C4915T and C5147A in L2. The mutations in E6 and L2 are silent, while the E7 mutation results in a single amino acid change. This study complements and expands on previous descriptions of HPV-18 variants. The sequence variation data presented here provides a foundation for future research on HPV-induced oncogenesis and may prove valuable for developing diagnostic probes and in the design of HPV vaccines for targeted populations.


Related Articles

  • HPV Screening Every Five Years Equal to Pap Smear Every Three Years. SHAUGHNESSY, ALLEN F. // American Family Physician;6/1/2014, Vol. 89 Issue 11, p907 

    The article examines whether human papillomavirus screening is an effective approach to identifying women at low risk of cervical cancer.

  • Cervical cancer: The smartest way to protect yourself. Clifford, Catherine // Redbook;Oct97, Vol. 189 Issue 6, p124 

    Provides information on cervical cancer. Human papillomavirus (HPV) as a causative agent of cervical cancer; Vulnerability of women to acquire cervical cancer; Importance of Pap smears; HPV testing as a way of detecting early cervical abnormalities. INSETS: The dangerous virus.;High-tech...

  • Single-round HPV testing reduced the rate of cervical cancer, death in rural Indian population. Adams, Stacey L.; Harris, Jason; Southall, Jennifer // Hem/Onc Today;5/10/2009, Vol. 10 Issue 9, p20 

    The article discusses research being done on HPV testing and cervical cancer death rate, referencing a study by R. Sankaranarayanan et al published in a 2009 issue of "New England Journal of Medicine."

  • Detection and Typing of Human Papilloma Viruses by Nested Multiplex Polymerase Chain Reaction Assay in Cervical Cancer. Kiani, Seyed Jalal; Malekshahi, Somayeh Shatizadeh; Ghalejoogh, Zohreh Yousefi; Ghavvami, Nastaran; Jandaghi, Nazanin Zahra Shafiei; Shahsiah, Reza; Jahanzad, Isa; Yavarian, Jila // Jundishapur Journal of Microbiology;Dec2015, Vol. 8 Issue 12, p1 

    Background: Cervical cancer is the leading cause of death from cancer in under-developed countries. Human papilloma virus (HPV) 16 and 18 are the most prevalent types associated with carcinogenesis in the cervix. Conventional Polymerase Chain Reaction (PCR), type-specific and consensus...

  • Diagnosis of human papillomarvirus infection by dry vaginal swabs in military women. Shah, Keerti V.; Daniel, Richard W.; Tennant, Marie K.; Shah, Nina.; McKee Jr., Kelly T.; Gaydos, Charlotte A.; Gaydos, Joel C.; Rompalo, Anne // Sexually Transmitted Infections;Aug2001, Vol. 77 Issue 4, p260 

    Objective: Human papillomavirus (HPV) assays are likely to be used with increasing frequency in clinical management of women with abnormal Papanicolaou smears and in cervical cancer screening. Our objective was to simplify the method of collection of female genital tract specimens. The utility...

  • Patient-collected vaginal specimens for HPV testing.  // Africa Health;Mar2012, Vol. 34 Issue 3, p58 

    The article focuses on a clinical trial in Mexico which reveals the benefit of human papillomavirus DNA (HPV DNA) testing of self-collected vaginal specimens in the detection of cervical cancer.

  • Primary HPV screening preferred in Europe.  // PharmacoEconomics & Outcomes News;3/17/2012, Issue 649, p4 

    The article reports on a study which advised European countries to consider switching from primary cytology to human papillomavirus (HPV) screening for cervical cancer.

  • HPV screening beats cytology for cervical Ca.  // Pulse;10/26/2011, Vol. 71 Issue 35, p13 

    The article focuses on the study conducted by U.S. researchers led by Evelyn Whitlock which shows the importance of human papillomavirus (HPV) screening in detecting cervical cancer among women aged 30 and over.

  • A breakthrough in cervical cancer treatment. Saunders, Carol S. // Patient Care;1/30/2000, Vol. 34 Issue 2, p70 

    Reports on a landmark group of studies released by the National Cancer Institute which shows that adding chemotherapy to radiation can reduce mortality by half in patients with cervical cancer. Prevention programs and advances in human papillomavirus testing that aid in the management of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics